Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study
Authors:
- Adam D. CohenACAdam D. Cohen
- Parameswaran HariPHParameswaran Hari
- Myo HtutMHMyo Htut
- Jesus G. BerdejaJBJesus G. Berdeja
- Saad Z. UsmaniSUSaad Z. Usmani
- Deepu MadduriDMDeepu Madduri
- Yunsi OlyslagerYOYunsi Olyslager
- Jenna D. GoldbergJGJenna D. Goldberg
- Jordan M. SchecterJSJordan M. Schecter
- Carolyn C. JacksonCJCarolyn C. Jackson
- Katharine S. GriesKGKatharine S. Gries
- John M. FastenauJFJohn M. Fastenau
Open Access
- 11 October 2022
- journal article
- research article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 23 (1) , 68-77
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Treatment preferences of patients with relapsed and refractory multiple myeloma: a qualitative studyBMC Cancer, 2019
- Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapyLeukemia, 2019
- Patient‐reported outcomes of multiple myeloma patients treated with panobinostat after ≥2 lines of therapy based on the international phase 3, randomized, double‐blind, placebo‐controlled PANORAMA‐1 trialBritish Journal of Haematology, 2018
- Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An UpdateDrugs, 2017
- Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta‐analysisEuropean Journal of Haematology, 2016
- What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life toolsEuropean Journal of Haematology, 2012
- Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1Blood, 2011
- Health related quality of life in a nationally representative sample of haematological patientsEuropean Journal of Haematology, 2009
- Changes in Quality-of-Life and Psychosocial Adjustment among Multiple Myeloma Patients Treated with High-Dose Melphalan and Autologous Stem Cell TransplantationTransplantation and Cellular Therapy, 2009
- Expectations and quality of life of cancer patients undergoing radiotherapyJournal of the Royal Society of Medicine, 2000